Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinom

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon Dec 23, 2024 3:51pm

157 Views

Post# 36375514

RE:RE:RE:RE:BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinom

Pre- BTD meeting was scheduled for late Dec or Jan if memory recalls correctly. Hopefully, no change to that. Not that anything ever gets delayed. I know MP is looking forward to 2025, whatever that means. Merry Christmas all

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks